Archive: 2023
4 Ways Linking CAR-T Therapy Patients to Real-world Data Is Future-proofing Clinical Development
Reading Time: 4 minutesChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant… Read More
Risk-based Quality Management Growing Rapidly in Clinical Trials: ACRO RBQM Working Group
Reading Time: 2 minutesClinical trials are constantly evolving in response to technological advances, new… Read More
Accelerating Generalizability of Cancer Clinical Trial Results
Reading Time: 4 minutesSubstantial research suggests that patients participating in cancer clinical trials of new therapies… Read More
2022: A Remarkable Year for External Control Arms in Clinical Trials
Reading Time: 5 minutes2022 was a remarkable year for external control arms (ECAs) in… Read More
Introducing the Medidata Knowledge Hub
Reading Time: 2 minutesThe Medidata Knowledge Hub is a new, state-of-the-art… Read More
Case Study: A Clinical-Stage Biopharmaceutical Company Saves $800K in Data Costs and Doubles Patient-Level Data Coverage with Medidata AI
Reading Time: 3 minutesSummary After investing years and significant resources in clinical… Read More
Next Generation of Clinical Monitoring | Part 1: Detect Variability in Adverse Event Reporting
Reading Time: 4 minutesModern clinical trials continue to increase in complexity as they include… Read More
Recapping an Unforgettable NEXT New York 2022
Reading Time: 5 minutesMedidata NEXT New York 2022 was truly special, with… Read More
Medidata AI & Imunon Publish Findings in ASCO Journal of Clinical Oncology that Show a Historic Clinical Trial External Control Arm Provides an Actionable Efficacy Estimate Prior to a Randomized Trial
Reading Time: 2 minutesMedidata and Imunon Corporation—a… Read More
My Worst Nightmare in Randomization and Trial Supply Management: Accidental Unblinding
Reading Time: 7 minutesThis blog was written by Sheri Lillis, RTSM Solution… Read More
